Breaking AI & Tech News Analyzed

Monarch Collective believes that a number of Women’s Super League (WSL) clubs remain “afterthoughts” for their owners, receiving only marginal capital and expertise. Co‑founder Kara Nortman highlighted this concern during a recent interview.Last month, Monarch became the first women’s multi‑sport group by acquiring a minority stake in the Cleveland WNBA franchise, joining an ownership portfolio that already includes NWSL sides San Diego Wave and Boston Legacy, as well as German club Viktoria Berlin.Since establishing Monarch in 2023—four years after launching Angel City FC with Natalie Portman and Julie Uhrman—Nortman has held informal talks with roughly a dozen English clubs, though no deal has yet materialised. She declined to comment on ongoing negotiations with West Ham United’s women’s side, noting that finding the right English partner has proven “challenging”.Recent years have seen a wave of international interest in WSL clubs, yet many prospective investors perceive the women’s teams as a compliance tool for profitability and sustainability mandates rather than a growth engine. In the past twelve months, clubs such as Chelsea, Aston Villa and Everton have sold stakes in their women’s sides to related‑party entities, while US‑based Bay Collective recently secured majority ownership of Sunderland Women in the WSL2.Monarch’s latest $250 million funding round equips it with the capital to act when a suitable opportunity arises. Nortman explained, “If owners truly believe in their women’s team, they should invite us to ‘supercharge’ it with our cross‑sport expertise. If they only want a token boost, that’s a different story.”Beyond capital, Monarch offers advisory services. Nortman recounted a humorous encounter with fans at Crystal Palace, where a supporter asked if she was a “Wag”, prompting a light‑hearted response that underscored the firm’s community‑focused ethos.Reflecting on Angel City’s trajectory, Nortman noted that Monarch initially invested about $1 million to help the club join the NWSL in 2020. Four years later, Angel City was sold to Disney CEO Bob Iger and his wife for a reported $250 million, making it the world’s most valuable women’s franchise.Looking ahead, Monarch is broadening its scope beyond football and basketball, exploring opportunities in cricket and rugby union. The firm recently opened a London office, led by former Manchester City executive Katharine Curran, to deepen its engagement with the UK sports market.

The Olivier Awards, a prestigious event in the theatre world, recently took place, and among the many memorable moments were the quotes shared by the winners. Host Nick Mohammed kicked off the ceremony with a lighthearted remark about the opening gondola scene from Phantom of the Opera, joking that it wasn't Cunard's boat, but rather Andrew Lloyd Webber's mode of transportation.Cole Escola, playwright of Oh, Mary!, expressed gratitude to a rather unconventional recipient: "my amazing husband, who doesn’t exist". This humorous comment set the tone for a night filled with both laughter and heartfelt acknowledgments.Elaine Paige, a special award winner, shared the secret to her long-lasting career, attributing her success to her father's motto: "perseverance furthers". This insight into her personal life added a touching element to the evening.Rachel Zegler, winner of the best actress in a musical for her role in Evita, recalled her experience performing in the Palladium balcony, calling it "the honour of a lifetime". Her sentiment encapsulated the pride and gratitude felt by many of the winners.Rosamund Pike, best actress winner, reflected on the challenges of balancing life and art, acknowledging the support of her family and partner. Her words resonated with the audience, highlighting the importance of a strong support system.The ceremony also saw Jack Holden win the surprise best actor award, who, upon hearing his name, jokingly asked, "It was definitely me, was it?". This lighthearted moment brought humor to the event.Throughout the evening, winners shared their appreciation for their loved ones and mentors. James Hameed thanked his dad, who had come to London to chase his dreams, showcasing the impact of family on one's journey to success.

Elizabeth Allen, a visionary artist known for her vibrant textile works, lived a reclusive life in a dilapidated hut in Biggin Hill, Kent. Her journey to fame began unexpectedly in 1965 when artist Patrick Heron visited her, leading to a series of exhibitions across Britain and internationally.Allen's work, characterized by its naive style and use of recycled materials, often depicted scenes from her life, including her orthopaedic footwear and a notable piece titled The Great Swan Song, which reflects her surprise at sudden fame. Her textiles also addressed social issues like the independence of African nations.Despite her brief moment in the spotlight, Allen's work was largely forgotten after her death in 1967. However, her art has been rediscovered and is now featured in the exhibition Troublemakers and Prophets at Compton Verney in Warwickshire. The exhibition includes pieces that have been stored away for decades, offering a fresh perspective on Allen's life and work.Curator Ila Colley highlights Allen's critical view of the church and her use of the Bible as inspiration for many of her pieces. The exhibition also features Autobiraggraphy, a textile work that includes scenes from Allen's life, such as her eviction by police in 1934.The exhibition aims to rediscover marginalized artists like Allen and provide a more inclusive view of art history. Colley hopes that this exhibition will lead to the discovery of more works by Allen and a deeper understanding of her life.

On a recent weekday evening, a special bus tour whisked art lovers through over twelve galleries and museums that stayed open until midnight, offering a late‑night glimpse of the Abidjan Art Week programme.The after‑hours event, dubbed the Night of the Galleries, was first trialled in January 2024 alongside the Africa Cup of Nations – a tournament that Côte d’Ivoire both hosted and won – and has become a staple of the festival’s third edition, which ran from Tuesday to Sunday.Since its inception, the week has broadened its footprint, moving beyond the city centre to include venues such as the La Rotonde des Arts contemporary‑arts hub in the Plateau district and the Adama Toungara Museum of Contemporary Cultures (MuCAT) in the working‑class neighbourhood of Abobo.Local collectors are emerging in force. MuCAT has hosted the Africa Foto Fair each year since 2022, and the Marché des Arts du Spectacle d’Abidjan – the city’s answer to the Dakar Biennale – is set to launch its 14th edition later this month.A graffiti festival launched two years ago has transformed the perception of street art, with vibrant murals now adorning the façade of the La Pyramide building and several upscale hotels in Plateau.Organisers stress that the festival’s growth should be independent of external validation. This year’s roster featured artists from Cameroon, the Democratic Republic of the Congo and Mali, and the number of participating galleries more than doubled compared with previous editions.Founder Yacouba Konaté, who also directs La Rotonde des Arts, highlighted the festival’s commitment to accessibility, arguing that art should not be seen as an elite pastime.The opening tribute honoured Simone Guirandou‑N’Diaye, a pioneering Ivorian art historian whose legacy lives on through Galerie LouiSimone Guirandou, now run with her daughter Gazelle.Among the week’s highlights, MuCAT presented Murmures d’Archives, a quieter, archival‑focused exhibition that concluded with an artists’ workshop and a DJ set.In the upscale Cocody district, New York‑based artist Ouattara Watts staged a solo show at Galerie Cécile Fakhoury, drawing the Ivorian diaspora into dialogue with the local scene. Watts explained that his work aims to transcend borders, describing it as “a vision that goes beyond any map – it is the cosmos that I paint.”

Conversations about mundane topics are often dreaded, but research suggests that people enjoy them more than they anticipate. A study involving 1,800 volunteers found that participants enjoyed chatting about dull subjects, such as the stock market or vegan diets, more than they expected. The findings indicate that by avoiding potentially dull exchanges, individuals may miss out on the mood boost and health benefits that come with connecting with others. Elizabeth Trinh, a PhD candidate in management and organisations at the University of Michigan, noted that people tend to underestimate how interesting and enjoyable conversations about boring topics can be. Trinh and her colleagues conducted a series of experiments to gauge how people responded to conversations on dull topics. Participants were asked to predict how much they would enjoy discussing topics they considered boring, and then engage in brief conversations about those topics. The results, published in the Journal of Personality and Social Psychology, showed that people consistently found the conversations more enjoyable than they expected. The surprise enjoyment arises because individuals base their expectations on static components, such as the topic and the other person, rather than dynamic components, like the conversation itself. Trinh suggests that people may benefit from lowering the bar for what makes a conversation worth having and reframing conversational goals. Instead of focusing on enjoyment, individuals could think about what they might learn from the conversation. Nicholas Epley, a professor of behavioural science at the University of Chicago, added that the fear of a boring conversation shouldn’t prevent people from starting one. “If a conversation is boring once you’re in it, you also have a surprising amount of power to make it better!”

Justin Rose secured a joint‑third place at the 2026 Masters, ending the tournament two shots behind defending champion Rory McIlroy. The result marked Rose’s third top‑six finish in his last eight major appearances. After a heartbreaking playoff loss to McIlroy at Augusta in 2025, Rose entered Sunday’s final round with the lead on the back‑nine but ultimately carded a final‑round 70 following a stumble at the famed Amen Corner. Reflecting on his performance, Rose said, "In the last two years I’ve really re‑kicked and re‑energised my career. I now have a lot of belief that there’s plenty of runway ahead." The 45‑year‑old, who claimed a PGA Tour victory in February, believes his recent form positions him to compete for future major titles. Rose emphasized that the majors are the events that drive his preparation: "These are the tournaments I focus on, the ones that make me put in that extra mile to show up and stay in these great arenas." His record at Augusta is notable, with eight top‑10 finishes and two runner‑up finishes, underscoring his affinity for the course. Rose cited veterans such as Freddie Couples and Bernhard Langer as inspirations, noting that the layout of Augusta rewards deep course knowledge and a personal playing style. Englishman Tyrrell Hatton also made headlines, posting a spectacular final‑round 66 that included six birdies and an eagle, propelling him to a joint‑third finish – his best performance in a major to date. Hatton explained his approach: "I try not to treat majors any differently – I go out every day, every round, every shot, and give it my best. I’m looking at ways to fine‑tune my preparation, perhaps more putting early in the week, to feel even more ready." Now in his tenth Masters, Hatton highlighted his steady improvement, citing recent top‑10 finishes at the U.S. Open and a rise from a tied‑fourteenth to a tied‑ninth in the last three years at Augusta.

Chala Chala Nav Bala (Maze Baal, 1943) marks the debut of Asha Bhosle, who entered the film world at ten years old. Paired with her sister Lata Mangeshkar, her bright falsetto captures the youthful innocence of the Marathi romance, foreshadowing the emotive style that would define her career. Aaiye Meherbaan (Howrah Bridge, 1958) showcases Bhosle’s rise during Hindi cinema’s golden age, thanks to her partnership with composer O.P. Nayyar. The song’s sultry vibrato and lush orchestration set the tone for the film’s noir atmosphere, establishing her as a leading‑lady playback voice. Aao Huzoor Tumko (Kismat, 1968) became a chart‑topping hit, featuring intricate vocal runs over a flamenco‑style guitar. Bhosle’s lower‑register chorus broke the conventional shrillness of female playback, while her nuanced phrasing added depth to the on‑screen heroine’s drunken allure. Dum Maro Dum (Hare Rama, Hare Krishna, 1971) stands out as her most successful crossover, later sampled by Western rappers. The track, produced with R.D. Burman—her future husband—blends psychedelic Beatles‑inspired grooves with Hindi lyrics, demonstrating her ability to bridge Eastern and Western pop sensibilities. Piya Tu Ab To Aaja (Caravan, 1971) pushes the fusion further into jazz‑cabaret territory, with bold horn sections and cinematic guitar reverb. Bhosle’s breathy, suggestive delivery sparked controversy, yet the performance remains a masterclass in balancing sensuality with technical agility. Chura Liya Hai Tumne Jo Dil Ko (Yaadon Ki Baaraat, 1973) epitomises the “masala” film soundtrack, merging drama, romance, and crime. Over a gentle guitar backdrop, Bhosle’s tender humming conveys quiet longing, contrasting with the film’s high‑octane narrative. In Ankhon Ki Masti (Umrao Jaan, 1981) sees Bhoske venture into Urdu ghazals with composer Khayyam. Her lower, huskier timbre—adjusted a half‑step down—highlights her continued artistic experimentation even as she approached fifty. Bow Down Mister (1991) illustrates her early 1990s foray into international collaborations, lending wordless, soaring vocals to Boy George’s post‑Culture Club project. The track transforms into a rave‑infused anthem, underscoring Bhosle’s versatility across genres. Radha Kaise Na Jale (Lagaan, 2001) pairs Bhosle with a young A.R. Rahman, reaffirming her status as an elder stateswoman of Indian music. The duet with Udit Narayan blends tabla and flute with powerful vocal runs, marrying traditional Hindustani scales to contemporary film scoring. The Way You Dream (2002) features an unexpected partnership with REM frontman Michael Stipe on the 1 Giant Leap project. The eight‑minute piece weaves tabla rhythms, subtle guitar, and a dramatic breakbeat, proving that Bhosle’s voice can seamlessly inhabit New Age and electronic soundscapes.

Recent CDC data reveal a dramatic 1,200% increase in kratom‑related poisonings across the United States over the last ten years, with the most pronounced surge recorded in 2025. Researchers link this rise to the growing presence of 7‑hydroxymitragynine (7‑OH), a synthetically produced compound that mimics kratom’s effects but carries opioid‑like risks. Walter Prozialeck, pharmacology professor at Midwestern University, said the trend was expected, noting that the synthetic alkaloid has entered the market through energy drinks and other products since 2024. Christopher McCurdy of the University of Florida warned that marketing 7‑OH as “enhanced kratom” blurs the line for consumers, turning poison‑control calls into a conflated metric for both natural and synthetic products. By contrast, natural kratom (Mitragyna speciosa)—a Southeast Asian plant used for centuries as a pain reliever—has demonstrated a relatively favorable safety profile in animal and human studies. A 2018 statement from then‑HHS Secretary Brett Giroir rejected the DEA’s push to schedule kratom as a Schedule I substance, citing insufficient evidence of harm. Despite the scientific distinction, several states have moved to implement or propose blanket bans on all kratom products, prompting concern from clinicians and patient advocates. A recent user survey indicated that about 50% of respondents rely on kratom for chronic pain, while roughly 40% use it during addiction recovery. Personal testimonies underscore the plant’s therapeutic role. Jeff Maslan, a 68‑year‑old Californian with severe osteoarthritis, credits kratom with easing opioid withdrawal after multiple surgeries. Similarly, “Steven,” a disabled California resident, describes how kratom eliminated unbearable oxycodone withdrawal symptoms without producing the euphoric “warm fuzzy” feeling typical of opioids. Researchers emphasize that 7‑OH carries genuine opioid hazards, including addiction, severe withdrawal, and respiratory depression that can lead to fatal overdose. In animal models, 7‑OH demonstrated the same respiratory‑depression risk as classic opioids, whereas kratom’s primary alkaloid did not. Prozialeck and colleagues explain that kratom’s pharmacology is more nuanced: it partially activates opioid receptors while also engaging adrenergic and serotonin pathways, resembling a hybrid of a weak opioid and an SNRI‑type antidepressant. This multimodal action likely accounts for its lower euphoric potential and the reported boost in energy among users. Nevertheless, experts caution that kratom is not without risk. Fatal poisonings often involve co‑ingestion of potent opioids such as fentanyl, suggesting that some users may cycle between kratom and stronger substances, raising overdose danger due to reduced opioid tolerance. Additionally, heavy‑metal contamination has been detected in certain kratom batches, though the source—soil, processing, or storage—remains unclear. Given these complexities, the consensus among scholars like Austin Zamarripa (Johns Hopkins) is that natural kratom should remain accessible, while concentrated 7‑OH products merit stricter regulation. “These products may offer meaningful benefits to some individuals, and those benefits could be lost if access is restricted too broadly,” Zamarripa said, urging a differentiated policy approach. As the debate unfolds, patients like Steven worry that a sweeping ban would ignore the nuanced safety profile of the plant. “There’s corn on the cob, there’s high‑fructose corn syrup, there’s whiskey— all derived from corn but fundamentally different,” he remarked, highlighting the need for targeted, evidence‑based regulation rather than a one‑size‑fits‑all prohibition.

Scientists at London's Institute of Cancer Research and the RCSI University of Medicine and Health Sciences in Dublin have announced a new AI-driven approach to identify how patients with advanced bowel cancer will respond to bevacizumab, a drug recently introduced by the NHS. The method uses PhenMap, an AI tool that integrates complex data on the genetic makeup of tumors, allowing researchers to track patterns of how different patients react to the drug. This development aims to spare potentially thousands of patients from being given drugs that would be ineffective in fighting their cancers. In the UK alone, nearly 10,000 cases of advanced bowel cancer are identified every year, with young adults seeing a particular rise in diagnoses. Bowel cancer has the second-highest mortality rate of any cancer, behind only lung cancer. While survival rates can be as high as 98% when caught early, the five-year survival rate for advanced bowel cancer can be as low as 10%. The study tracked 117 European bowel cancer patients who had been treated with chemotherapy and bevacizumab. Researchers identified a group of patients who all had the same gene mutation and were at a high risk of having negative reactions. The scientists behind the tests now hope to expand the number of patient samples and see if the results can be used in treatments for other types of cancer. Anguraj Sadanandam, a professor in stratification and precision medicine at the ICR, said: “Once bowel cancer spreads to other parts of the body, there are very few treatment options available for patients. It is therefore positive that patients can now access the targeted drug bevacizumab on the NHS. However, we know that the majority of patients won’t benefit from the drug, meaning thousands of people in England could be facing unpleasant side effects unnecessarily.” Sadanandam added that while the findings were encouraging, the tool would need to be tested on a larger cohort to be validated. “In future, I hope this approach will lead to a test that can be used by clinicians, to ensure patients receive personalised care that has the highest chance of working against their cancer.”